A successful experience using labetalol and hemodialysis to treat near-fatal caffeine poisoning: a case report with toxicodynamics - Ou HC, Deng JF, Yang CC, Lin CS, Mao YC, Tsai SH, Ho CH.
We present an 18-year-old male who attempted suicide with 295 mg/kg pure caffeine powder (lethal oral dose: 150-200 mg/kg) and was successfully rescued. He pres... (Source: SafetyLit)
Source: SafetyLit - December 22, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The Vials
Hospira, Inc., a Pfizer company, is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus ® (NDC 0409-2267-25) to the hospital/institution level. Hospira, Inc. initiated this recall due to the discovery of cracks on the rim surface of vials for these lots, which is covered by the stopper and crimp seal. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Metoprolol vs. labetalol
Title: Metoprolol vs. labetalolCategory: MedicationsCreated: 5/13/2019 12:00:00 AMLast Editorial Review: 5/13/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 13, 2019 Category: Drugs & Pharmacology Source Type: news
Information from the Department of Health and Social Care (DHSC) on supply issue with labetalol tablets, all strengths
DHSC has been made aware of a supply issue with ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 12, 2019 Category: Drugs & Pharmacology Source Type: news
Labetalol Use Up for Patients With Preeclampsia and Asthma
Use of labetalol versus other antihypertensives linked to increased risk of status asthmaticus (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 15, 2018 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Gynecology, Pharmacy, Pulmonology, Journal, Source Type: news
Labetalol Use Up for Patients With Preeclampsia and Asthma
WEDNESDAY, Aug. 15, 2018 -- Higher rates of β-blocker use are seen among women with preeclampsia and asthma, according to a study published in the July issue of Obstetrics& Gynecology.
Whitney A. Booker, M.D., from Columbia University in New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 15, 2018 Category: Pharmaceuticals Source Type: news
Labetalol Hydrochloride Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 9, 2018 Category: Drugs & Pharmacology Source Type: news
Recommended Drugs for Severe Hypertension in Pregnancy Show Similar Efficacy, Safety Recommended Drugs for Severe Hypertension in Pregnancy Show Similar Efficacy, Safety
Nifedipine, hydralazine and labetalol have similar efficacy and negligible differences in their safety profile, and are likely comparable for treating severe hypertension in pregnancy, according to a recent network meta-analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The Vials
Hospira, Inc., a Pfizer company, is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus ® (NDC 0409-2267-25) to the hospital/institution level. Hospira, Inc. initiated this recall due to the discovery of cracks on the rim surface of vials for these lots, which is covered by the stopper and crimp seal. (Source: Food and Drug Administration)
Source: Food and Drug Administration - February 23, 2018 Category: Food Science Source Type: news
Labetalol Hydrochloride Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 12, 2017 Category: Drugs & Pharmacology Source Type: news
